Johnny Yao

Company: Voyager Therapeutics

Job title: Director - Pharmacology & Translational Research


Navigating Several Aspects of Preclinical Studies to Improve Translational Safety & Success of AAV Gene Therapies 10:00 am

• Delving into de-targeting of AAV vectors to minimize safety concerns • Highlighting concerns relating to AAV toxicity in NHP studies and possible methods to mitigate potential toxicity during in life study • Exploring how to optimally use animal models to detect early signs of toxicityRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.